Brain 18-FDG-PET patterns in early breast cancer subtypes: Relationship with headache.
Rita De Sanctis(Humanitas University), Armando Santoro(IRCCS Humanitas Research Hospital), Lidija Antunovic(Humanitas University), Mariangela Gaudio(Humanitas University), Flavia Jacobs(Fondazione IRCCS Istituto Nazionale dei Tumori), Arturo Chiti(Vita-Salute San Raffaele University), C. Benvenuti, Mariya Boyanova Ilieva(Humanitas University), Alessandro Viganò(Sapienza University of Rome)
Cited by 0
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
|JAMA|2014|569
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
|The Lancet Oncology|2012|550
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532